Sprout’s Libido Pill Won’t Come Close To Viagra’s Impact
The FDA has approved a controversial drug designed to enhance a woman’s sexual drive. Addyi (generic name: flibanserin), from Sprout Pharmaceuticals, acts in the brain to enhance a woman’s libido. By taking one pill a day for a month, clinical trials showed that women on Addyi on average increased their number of satisfying sexual events by one a month from a baseline of 2 -3. That’s obviously not an enormous amount, but there is a subset of women for whom the drug had a better effect and, for them, the drug may prove to be of value. It was these data that led the FDA to approve Addyi.
Source: BioSpace Featured Stories